Search Results 2091-2100 of 17336 for Fructose
ROCHESTER, Minn. — A new Mayo Clinic study published in the New England Journal of Medicine has uncovered that an off-the-shelf, dual-antibody therapy can ...
Mayo Clinic study shows AI could enable accurate, inexpensive screening for atrial fibrillation featured image · Discovery of distinct lung cancer pathways may ...
Mayo Clinic's biomedical ethics team reaches milestone in patient-centered research featured image · Use of anticoagulant drug after aortic valve replacement ...
ROCHESTER, Minn. — A study at Mayo Clinic suggests that an hourglass-shaped stent could improve blood flow and ease severe and reoccurring chest pain in[.
ROCHESTER, Minn. — Dec. 16, 2013 — Mayo Clinic researchers and colleagues in Belgium have developed a specialized catheter for transplanting stem cells into ...
2024 marks a pivotal year for advancing artificial intelligence (AI) solutions in healthcare, requiring multidisciplinary teamwork and scientific rigor to bring ...
Nonalcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease in the world and a major public health issue in the US. It is ...
Health & Wellness · Mayo Clinic Minute: Nonsurgical treatment for uterine fibroids featured image · Mayo hospitals earn highest grades for patient safety from ...
Chimeric antigen receptor-T cell therapy (CAR-T cell therapy) could provide a revolutionary approach to organ transplantation for patients who are hard to match ...
The late Mayo endocrinologists Russell Wilder, M.D., and Randall Sprague, M.D., would be smiling today at the news for patients with diabetes.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.